Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel.

Slides:

Advertisements

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Advertisements

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

Tuomo Puhakka, MDa, Mika J

House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: A possible delay in the manifestation of.

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome Paul Steinberg, MDa, Bruce E.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Kiwi fruit allergy: A new birch pollen–associated food allergy

Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction Robert A. Nathan, MDa, Jonathan A.

Kiwi fruit allergy: A new birch pollen–associated food allergy

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma Patrick Booms, MSca, David.

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Practice Notes from the AAAI

David P. Skoner, MD, Betty L

Badrul A. Chowdhury, MD, PhD

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia Carol K. Fosso, MDa,

Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial William Busse, MDa,

Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol Henry Milgrom, MDa, David P. Skoner,

Conjunctivitis medicamentosa

Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma Nhan Pham-Thi, MD, Jacques de Blic, MD,

High-resolution computed tomography scan and airway remodeling in children with severe asthma Jacques de Blic, MD, Isabelle Tillie-Leblond, MD, PhD,

Michael Mellon, MD Journal of Allergy and Clinical Immunology

Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthma Gail.

Practice Notes from the AAAAI

Randomized, double-blind, crossover challenge study in 53 subjects reporting adverse reactions to melon (Cucumis melo) Julia Rodriguez, MDa, Jesus F.

Paul M. O’Byrne, MB, FRCPI, FRCP(C)a, Soren Pedersen, MD, PhDb

A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations John H. Toogood, MD,

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model John M.

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

News & Notes Journal of Allergy and Clinical Immunology

Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype Atsuko Takao, MDa, Terufumi Shimoda, MDa, Shigeru Kohno, MDa, Sadahiro.

James P. Kemp, MDa, David A. Cook, MDb, Gary A

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma William.

Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.

Jack M. Becker, MDa, Anjali Arora, MDb, Richard J

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Vascular endothelial growth factor in patients with acute asthma

News & Notes Journal of Allergy and Clinical Immunology

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma Eugene R. Bleecker, MDa, Michael J. Welch, MDb,

Occupational allergy caused by urticating hair of Brazilian spider

Omalizumab improves asthma-related quality of life in patients with severe allergic asthma Albert Finn, MDa, Gary Gross, MDb, Julius van Bavel, MDc,

A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein.

Sex difference in Fel d 1 allergen production

The 30th anniversary of the American Board of Allergy and Immunology: Then and now Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.

Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective Helen Donohoe, MSc (Econ)

Practice Notes from the AAAI

The natural progression of peanut allergy: Resolution and the possibility of recurrence David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa,

Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen Catherine.

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma James P.

Anaphylaxis after initial ingestion of rambutan, a tropical fruit

Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway.

Tuomo Puhakka, MDa, Mika J

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy Diane J. Pincus, MD, Teresa R. Humeston,

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

Footnotes1 Journal of Allergy and Clinical Immunology

Macrolide antibiotics and asthma treatment

Larry C. Borish, MDa, Harold S

Prognostic factors and long-term results after thymoma resection: A series of 307 patients Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.

News & Notes Journal of Allergy and Clinical Immunology

Primary prevention of asthma and allergy

Presentation transcript:

Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel Le Bourgeois, MDa, Bruno Mahut, MDa, Juliette Ostinelli, MDb, Carole Caswell, MScc, Pierre Scheinmann, MDa Journal of Allergy and Clinical Immunology Volume 98, Issue 1, Pages 14-20 (July 1996) DOI: 10.1016/S0091-6749(96)70221-X Copyright © 1996 Mosby, Inc. Terms and Conditions

FIG. 1 Percentage of patients without exacerbation of asthma in budesonide and placebo groups during treatment and follow-up periods. Journal of Allergy and Clinical Immunology 1996 98, 14-20DOI: (10.1016/S0091-6749(96)70221-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

FIG. 2 Proportion of days and nights with symptoms during the treatment period in the budesonide group (Solid Square) and in the placebo group (Open Square). (Values are expressed as means ± SD.) NS, Not significant. Journal of Allergy and Clinical Immunology 1996 98, 14-20DOI: (10.1016/S0091-6749(96)70221-X) Copyright © 1996 Mosby, Inc. Terms and Conditions